NCT00792142
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chemically-Induced Disorders, +18 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Clinical trial condition
Hemostatic Disorders
Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.
3,079 public trials
581 recruiting studies
Hemostatic Disorders trial results
NCT03383055
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States
NCT02849444
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Hospital Torrecárdenas Almería, Andalusia, Spain
- Hospital Universitario Puerta del Mar Cadiz, Andalusia, Spain
- Hospital Virgen de la Nieves Granada, Andalusia, Spain
- Hospital Universitario Ciudad de Jaen Jaén, Andalusia, Spain
NCT01720875
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Nottingham University Hospital Nottingham, Nottinghamshire, United Kingdom
- University Hospital Southampton Southampton, United Kingdom
NCT00421525
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Winship Cancer Institute, Emory University Atlanta, Georgia, United States
- Center for Cancer Care Goshen, Indiana, United States
- Hackensack University Medical Center Hackensack, New Jersey, United States
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT00003816
- Conditions
- Anemia, Anemia, Aplastic, Anemia, Refractory, +90 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT02640287
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- CHRU Nancy Vandœuvre-lès-Nancy, France
Completed
A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013/KEYNOTE-013)
NCT01953692
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +27 more
- Locations
-
Not specified
NCT02992483
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- MD Anderson Cancer Center/University of Texas MD Anderson CC Houston, Texas, United States
- Novartis Investigative Site Heidelberg, Victoria, Australia
- Novartis Investigative Site Nantes, France
- Novartis Investigative Site Heidelberg, Germany
NCT01794507
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- University of Arizona Cancer Center - North Campus /ID# 117876 Tucson, Arizona, United States
- Mayo Clinic /ID# 121495 Jacksonville, Florida, United States
- Northwestern University Feinberg School of Medicine /ID# 117477 Chicago, Illinois, United States
- University of Michigan Hospitals /ID# 80353 Ann Arbor, Michigan, United States